LARVOL Revenue and Competitors
Estimated Revenue & Valuation
- LARVOL's estimated annual revenue is currently $24.2M per year.
- LARVOL's estimated revenue per employee is $154,000
Employee Data
- LARVOL has 157 Employees.
- LARVOL grew their employee count by -12% last year.
LARVOL's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Oncology | Reveal Email/Phone |
2 | VP - Product Management | Reveal Email/Phone |
3 | VP, Global Operations | Reveal Email/Phone |
4 | Director - KOL & Life Sciences Strategy | Reveal Email/Phone |
5 | Director Product Development | Reveal Email/Phone |
6 | Senior Customer Success Manager | Reveal Email/Phone |
7 | Product Design Manager | Reveal Email/Phone |
8 | Associate Manager | Reveal Email/Phone |
9 | Associate Manager | Reveal Email/Phone |
10 | Associate Manager | Reveal Email/Phone |
LARVOL Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 17 | N/A | N/A | N/A |
#2 | $0.6M | 8 | 0% | N/A | N/A |
#3 | $13.2M | 94 | 6% | N/A | N/A |
#4 | $78.4M | 441 | 0% | $6.8M | N/A |
#5 | $12M | 86 | -1% | N/A | N/A |
#6 | $66.1M | 372 | -3% | $131.5M | N/A |
#7 | $0.6M | 8 | -50% | N/A | N/A |
#8 | $0.3M | 4 | 33% | N/A | N/A |
#9 | $0.6M | 9 | N/A | N/A | N/A |
#10 | $2.6M | 27 | N/A | N/A | N/A |
What Is LARVOL?
Customized intelligence reports and SaaS solutions - We provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Our products include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.
keywords:N/AN/A
Total Funding
157
Number of Employees
$24.2M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LARVOL News
SAN FRANCISCO--(BUSINESS WIRE)--Feb 23, 2021-- LARVOL, leading provider of intelligence and data solutions to pharma and life science teams, today welcomes Mark Lagunowich as Vice President, Global Sales. “We are thrilled to welcome Mark to the team at LARVOL,” said founder and CEO Bruno Larvo ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.4M | 157 | -5% | $335M |
#2 | $7.5M | 157 | 22% | N/A |
#3 | $46.6M | 157 | 8% | N/A |
#4 | $36.3M | 157 | 8% | N/A |
#5 | $22.1M | 158 | 4% | $40M |